The implications of novel oral anticoagulation in ocular surgery
The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - Thrombosis Research
Anticoagulation in Atrial Fibrillation – Current Concepts | AER Journal
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper - ScienceDirect
Direct-acting Oral Anticoagulants in Dermatologic Surgery - ScienceDirect
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram
Pharmacology of anticoagulants used in the treatment of venous thromboembolism | SpringerLink
Mechanism of action of dabigatran, rivaroxaban and warfarin. | Download Scientific Diagram
Perioperative Management of New Anticoagulants: Novel Drugs and Concepts - Anesthesia Patient Safety Foundation
A New Generation of Oral Direct Anticoagulants | Arteriosclerosis, Thrombosis, and Vascular Biology
Novel Oral Anticoagulant Reversal in Acute Hemorrhage - ppt download
Direct Oral Anticoagulants: A User's Guide | Consultant360
Mechanism of action of the non-vitamin K antagonist oral anticoagulants... | Download Scientific Diagram
Anticoagulant - Wikipedia
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction | Revista Española de Cardiología
Reversal of Apixaban and Rivaroxaban Anticoagulation by Andexanet Alfa in ANNEXA-A and ANNEXA-R as Assessed by Non-Tissue Factor-Initiated Thrombin Generation Independent of Tissue Factor Pathway Inhibitor - European Medical Journal
Rivaroxaban for the treatment and prevention of thromboembolic disease - Antoniou - 2015 - Journal of Pharmacy and Pharmacology - Wiley Online Library
Factor Xa inhibitors
Direct oral anticoagulants: evidence and unresolved issues - The Lancet
Coumadin 30 mg — online usps
![PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/64d620321dfe4fcc85537c0e0a6f9260a019b8fa/2-Figure1-1.png "PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar")
PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar
Episode 1: Factor Xa Inhibitor Reversal Using PCC with Brian Gilbert - The Pharm So Hard Podcast
Eliquis (Apixaban Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Dentistry Journal | Free Full-Text | New Direct Oral Anticoagulants (DOAC) and Their Use Today | HTML
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
The Direct Oral Anticoagulants Apixaban, Rivaroxaban, and Edoxaban | American Society for Clinical Laboratory Science
Direct Oral Anticoagulants: A User's Guide | Consultant360
